I pick Hiap Hoe and Q&M: Hiap Hoe: earnings and RNAV surge to come from projects built on cheap land 1. Skyline 360: net saleable space: 123,192 sq ft, land cost: $756psf, other cost: $450psf, breakeven: $1,206psf, average selling price: $1,950psf, gross profit = ($1,950-1,206) X 123,192 = $91.65 million. 2. Waterscape: net saleable space: 213,437 sq ft, land cost: $609psf, other cost: $430psf, breakeven: $1,035, average selling price: $1,750psf, gross profit = ($1,750-$1,035) X 213,437 = $152.6 million. 3. The Aspine (60% stake in project): net saleable space: 79,800 sq ft, land cost: $1,870psf, other cost: $450psf, breakeven: $2,320, average selling price: $2,000psf, gross profit = ($2,000-$2,320) X 79,800 X 60% = $15.32m loss (60% share of total loss) 4. Hotel/SOHO project in Ah Hood Road (50% stake in project). Gross floor area = 426,000 sq ft. Company bought the land at $172 psf, compared to analyst estimate of fair value of $350-470psf. To be conservative, we use a gross profit of only $250psf for this project. Gross profit = $250psf X 426,000 = $106.5 million, and Hiap Hoeââ¬â¢s 50% stake in it is equal to $53.35m. Total gross profit above = $282.28 million, compared with mkt cap of $166.4m. RNAV should surge to $1.08. Co will experience big earnings and RNAV growth next 1-3 years, with huge cash inflows in next 2-4 years. Co is one of the most exposed (in % terms of coââ¬â¢s projects) to the Orchard Road vicinity, and if analystsââ¬â¢ touting growth in prime area prices are correct, then it will not have problem selling its Orchard area condos. Itââ¬â¢s hotel exposure will also benefit if the IRs take off next few years. Q&M: low supply of such stocks (no other dental counter, and only one of few medical counters) and good demand means price may gain from simple law of supply and demand. But with high PE already, stock is riskier compared to Hiap Hoe.